New Cholinesterase Inhibitors Target Alzheimer’s with Thiadiazoles

Recent advancements in the field of medicinal chemistry have stirred a renewed interest in compounds that may revolutionize the treatment of neurodegenerative disorders, prominently Alzheimer’s disease. One promising class of compounds is the 1,3,4-thiadiazole derivatives, which have emerged as significant cholinesterase inhibitors. This class stands out due to its chemical versatility and potential therapeutic benefits, […]